• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Watson Pharma launches generic of J&J's Concerta

      Posted Atforbes.com

      Watson Pharmaceuticals Inc. said Monday it has started selling an authorized generic version of Johnson & Johnson's attention deficit hyperactivity disorder drug Concerta.

      Watson said sales of Concerta, or methylphenidate, totaled $1.5 billion in the year that ended Feb. 28.

      Concerta is to treat ADHD in children ages 6 to 17, and adults 18 to 65. It's an extended-release drug with the same active ingredient as Ritalin.

      Under an agreement the companies announced in November, Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceutical unit is making and supplying the drug, and it will receive a share of the revenue from sales. Watson will market and distribute the generic.

      The agreement lasts until the end of 2014. Watson can launch its own generic version when the deal ends.

      Watson is based in Parsippany, N.J., and Johnson & Johnson in New Brunswick, N.J. Shares of Watson rose $1.07 to $63.09 in afternoon trading. Johnson & Johnson's stock rose 42 cents to $66.14.

      May 04, 2011


      Share this Article!

    Back to top^